Table 4.
Model 1 |
Model 2 |
|||
---|---|---|---|---|
β* (95% CI) Volume CAC Scores |
p Value | β* (95% CI) Volume CAC Scores |
p Value | |
Overall (n = 2,755) | 15.01 (8.13–21.90) | <0.0001 | 9.39 (2.30–16.48) | 0.009 |
Whites (n = 1,256) | 18.54 (5.84–31.23) | 0.004 | 3.27 (—12.19–18.74) | 0.68 |
Chinese Americans (n = 328) | 16.46 (0.60–32.32) | 0.042 | 13.86 (—3.92–31.56) | 0.13 |
African Americans (n = 627) | 17.75 (3.42–32.08) | 0.015 | 8.43 (—6.31–23.17) | 0.27 |
Hispanics (n = 544) | 9.45 (—5.31–24.20) | 0.21 | 7.12 (—5.33–19.57) | 0.26 |
Regression coefficients are derived from median regression analysis. Model 1 adjusted for age, gender, race, MESA site, and follow-up duration. Model 2 adjusted for age, gender, race, MESA site, follow-up duration, body mass index, hypertension, diabetes mellitus, cigarette smoking, family history of CHD, LDL, HDL, triglycerides, and cholesterol-lowering medications. Race was not adjusted for race-specific analyses. Adjustment for type of scanner used to access CAC, systolic blood pressure as a continuous variable, creatinine, or estimated glomerular filtration rate had no significant impact on the results.